Amanote Research

Amanote Research

    RegisterSign In

Rituximab in Multiple Sclerosis at General Hospital Level

Acta Neurologica Scandinavica - United Kingdom
doi 10.1111/ane.13225
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineNeurology
Date

February 6, 2020

Authors
Johan HellgrenAnette RisedalKristina Källén
Publisher

Wiley


Related search

Experience With Long-Term Rituximab Use in a Multiple Sclerosis Clinic

Multiple Sclerosis Journal – Experimental, Translational and Clinical
2016English

Extensive Multiple Sclerosis Reactivation After Switching From Fingolimod to Rituximab

Case Reports in Neurological Medicine
2018English

Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study

Journal of Immunology Research
MedicineAllergyImmunology
2018English

Pain Level of Postoperative Orthopedic Patients at Dr. Soetomo General Hospital

Indonesian Journal of Anesthesiology and Reanimation
2019English

Changes in B- And T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis

Archives of Neurology
2010English

Proposed General Hospital at Putney

BMJ
1906English

Sex Differences in Comorbidity at Diagnosis of Multiple Sclerosis

Neurology
Neurology
2016English

sRage Plasma Level in Association With Multiple Sclerosis Risk in Slovak Population

SpringerPlus
Multidisciplinary
2015English

Rituximab in CD20 Positive Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy